MedTrace Logo

Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine

NCT01842230 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2013-08-01

No results posted yet for this study

Summary

The purpose of this study is to investigate the effect of Atorvastatin on the pharmacokinetic properties of Telmisartan/S-amlodipine

Conditions

Interventions

DRUG

Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg

* Telmisartan 80mg, S-amlodipine 5mg: 1 tablet, oral, once daily, 1day * Atorvastatin 40mg: 1 tablet, oral, once daily, 2days * over the period I \& II(cross-over)

DRUG

Telmisartan 80mg and S-amlodipine 5mg

* Telmisartan 80mg, S-amlodipine 5mg: 1 tablet, oral, once daily, 1day * over the period I \& II(cross-over)

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Min Soo Park, Ph. D · Severance Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-05-31
Completion
2013-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01842230 on ClinicalTrials.gov